Stock Track | Ardelyx Plummets 5.21% in Pre-market After Q1 Earnings Miss

Stock Track05-01

Ardelyx (ARDX) shares plummeted 5.21% in pre-market trading on Friday following the release of the company's first-quarter financial results.

The biopharmaceutical company reported a net loss of $0.15 per diluted share for Q1, which missed analyst expectations of a $0.14 loss. Despite revenue for the quarter coming in at $94.5 million and exceeding consensus estimates, investors appeared to focus on the earnings miss.

The market reaction suggests traders were digesting the mixed quarterly performance, with the earnings shortfall outweighing the positive revenue surprise in pre-market trading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment